Updated Jul 16, 2026 · Last SEC filing 2026-06-03
ONCOLYTICS BIOTECH INC (ONCY) has filed 14 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-03. 8 Form 8-K material event filings were reported by ONCY in the last 90 days. InsiderAlpha tracks every ONCY SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001129928 |
|---|
| Form 4 filings (90d) | 14 |
|---|---|
| Form 8-K filings (90d) | 8 |
| Latest Form 4 filing | 2026-06-03 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Kelly Jared | Chief Executive Officer | P — Open-market purchase | 5.0K | $0.96 | $5K | SEC | |
| Parsons James T. | Director | P — Open-market purchase | 10.0K | $1.03 | $10K | SEC | |
| Look Kirk | Chief Financial Officer | P — Open-market purchase | 12.0K | $0.84 | $10K | SEC | |
| Pisano Wayne | Director | P — Open-market purchase | 30.0K | $0.84 | $25K | SEC | |
| Heineman Thomas Charles | Chief Medical Officer | P — Open-market purchase | 12.1K | $0.83 | $10K | SEC | |
| Brown Deborah Margaret | Director | P — Open-market purchase | 25.0K | $0.85 | $21K | SEC | |
| Hagerman Allison | VP, Product Development | P — Open-market purchase | 10.0K | $0.83 | $8K | SEC | |
| Kelly Jared | Chief Executive Officer | P — Open-market purchase | 29.5K | $0.84 | $25K | SEC | |
| Seizinger Bernd R. | Director | P — Open-market purchase | 40.0K | $0.85 | $34K | SEC | |
| Andrews Patricia S | Director | P — Open-market purchase | 35.4K | $0.86 | $30K | SEC | |
| Aromando Andrew | Chief Business Officer | P — Open-market purchase | 29.6K | $0.86 | $25K | SEC | |
| Kelly Jared | Chief Executive Officer | P — Open-market purchase | 5.6K | $0.84 | $5K | SEC | |
| Seizinger Bernd R. | Director | P — Open-market purchase | 60.0K | $0.83 | $50K | SEC | |
| Seizinger Bernd R. | Director | P — Open-market purchase | 100.0K | $1.04 | $104K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for ONCOLYTICS BIOTECH INC (ONCY). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Pisano Wayne | 1 | — |
| Seizinger Bernd R. | 1 | — |
| Parsons James T. | 1 | — |
| Kelly Jared | 1 | — |
| Glover Stephen C. | 1 | — |
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ONCY insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live ONCY dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.